US Stock MarketDetailed Quotes
ADIL Adial Pharmaceuticals
- 1.7000
- +0.0100+0.59%
Close Apr 30 16:00 ET
6.89MMarket Cap-472P/E (TTM)
1.7700High1.6600Low236.71KVolume1.6900Open1.6900Pre Close407.13KTurnover6.01%Turnover RatioLossP/E (Static)4.05MShares14.000052wk High1.69P/B6.69MFloat Cap0.765052wk Low--Dividend TTM3.94MShs Float236.0000Historical High--Div YieldTTM6.51%Amplitude0.7650Historical Low1.7190Avg Price1Lot Size
About Adial Pharmaceuticals Company
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
Company Profile
SymbolADIL
Company NameAdial Pharmaceuticals
Listing DateJul 27, 2018
Founded2010
CEOMr. Cary J Claiborne
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4870 Sadler Road,Suite 300
CityGlen Allen
ProvinceVirginia
CountryUnited States of America
Zip Code23060
Phone1-434-487-8196
Websitehttp://www.adialpharma.com
Company Executives
- Name
- Position
- Salary
- Cary J Claiborne
- Director, President and Chief Executive Officer
- 1.02M
- Dr. Bankole A. Johnson, D.Sc.,M.D.
- Chief Medical Officer
- 6.33K
- Tony Goodman
- Director and Chief Operating Officer
- 124.17K
- Joseph Truluck, M.B.A.
- Principal Accounting Officer, Chief Financial Officer, Treasurer and Secretary
- 442.62K
- Kevin Schuyler, C.F.A.,M.B.A.
- Chairman of the Board and Lead Independent Director
- 108.17K
- James W. Newman, Jr
- Independent Director
- 106.17K
- Robertson H. Gilliland, M.B.A.
- Independent Director
- 100.17K
- J. Kermit Anderson
- Independent Director
- 103.17K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg